East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Abatacept
Orencia
Routinely available
NICE (TA195 (SMC 400/07))
02/03/2011

Indication

In combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to other disease-modifying anti-rheumatic drugs (DMARDs) including at least one tumour necrosis factor (TNF) inhibitor.

In combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to other disease-modifying anti-rheumatic drugs (DMARDs) including at least one tumour necrosis factor (TNF) inhibitor.

Therapeutic Area

Musculoskeletal and joint diseases

Status Description

Routinely available in line with national guidance

Formulation

250mg powder for concentrate for solution

Comments

March 2011 - Added to the Additional List, for Specialist Use only. August 2010 - NICE MTA advice: SMC advice 400/07 is superseded by NICE TA195. July 2019 (as per LJF) - Routinely available in line with national guidance. Included on the Additional List, for Specialist Use only.

Link to Advice

TA195 (SMC 400/07)

Advice Published

25/08/2010